Trials / Recruiting
RecruitingNCT02619890
Brain Glioma Registry Combining Clinical and Imaging Information
Registry Describing Clinical Information, Conventional, and Advanced Magnetic Resonance Imaging Information of Patients With Brain Glioma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,000 (estimated)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This registry aims to collect clinical and radiologic information including detailed clinical, conventional MR and advanced MR imaging data of patients with brain gliomas. Advanced MR imaging may include diffusion-weighted imaging, perfusion-weighted imaging (dynamic susceptibility contrast, arterial spin labeling, dynamic contrast enhancement), and chemical exchange saturation transfer (CEST) imaging. This registry will describe course of disease and long-term outcomes of brain gliomas.
Detailed description
Though the cure for brain glioma- from low grade to glioblastoma- is yet to be found, seeking for curable treatment option is actively developing. Multimodal advanced MR imaging (contrast-enhanced T1 weighted imaging, diffusion-weighted imaging, chemical exchange saturation transfer imaging, and perfusion imaging) on 3 Tesla have shown potential in patients with glioma to monitor treatment response with quantitative assessment. To find suitable imaging biomarker for treatment response, assessing clinical and radiologic outcome for long-term is essential. The creation of a registry for brain glioma in long-term follow up provides an overview of the clinical, relevant treatment standards, advanced MR imaging information, and survival data of patients and thus create opportunities for imaging biomarker research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Brain Glioma Registry |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2040-12-01
- Completion
- 2040-12-01
- First posted
- 2015-12-02
- Last updated
- 2024-05-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02619890. Inclusion in this directory is not an endorsement.